Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107455404 | 10745540 | 4 | F | 2013 | 20160818 | 20150128 | 20160823 | PER | US-PFIZER INC-2015031577 | PFIZER | 59.00 | YR | F | Y | 71.00000 | KG | 20160823 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107455404 | 10745540 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | J47755 | 21446 | 150 | MG | CAPSULE, HARD | BID | |||||
| 107455404 | 10745540 | 2 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 107455404 | 10745540 | 3 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 107455404 | 10745540 | 4 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 60 MG, DAILY | 0 | 60 | MG | |||||||||
| 107455404 | 10745540 | 5 | C | METOPROLOL. | METOPROLOL | 1 | 50 MG, DAILY | 0 | 50 | MG | |||||||||
| 107455404 | 10745540 | 6 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | 50 ?G, UNK | 0 | 50 | UG | |||||||||
| 107455404 | 10745540 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 112 ?G, DAILY | 0 | 112 | UG | |||||||||
| 107455404 | 10745540 | 8 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 107455404 | 10745540 | 9 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
| 107455404 | 10745540 | 10 | C | MECLIZINE HCL | MECLIZINE HYDROCHLORIDE | 1 | 25 MG, AS NEEDED | 0 | 25 | MG | |||||||||
| 107455404 | 10745540 | 11 | C | NITROFURANTOIN MONOHYDRATE | NITROFURANTOIN MONOHYDRATE | 1 | 100 MG, DAILY | 0 | 100 | MG | |||||||||
| 107455404 | 10745540 | 12 | C | ACYCLOVIR. | ACYCLOVIR | 1 | 400 MG, DAILY | 0 | 400 | MG | |||||||||
| 107455404 | 10745540 | 13 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107455404 | 10745540 | 1 | Fibromyalgia |
| 107455404 | 10745540 | 2 | Pain |
| 107455404 | 10745540 | 3 | Osteoarthritis |
| 107455404 | 10745540 | 4 | Pain |
| 107455404 | 10745540 | 5 | Extrasystoles |
| 107455404 | 10745540 | 6 | Hypersensitivity |
| 107455404 | 10745540 | 7 | Thyroid disorder |
| 107455404 | 10745540 | 8 | Depression |
| 107455404 | 10745540 | 9 | Insomnia |
| 107455404 | 10745540 | 10 | Dizziness |
| 107455404 | 10745540 | 13 | Asthma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107455404 | 10745540 | Drug effect incomplete | |
| 107455404 | 10745540 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107455404 | 10745540 | 1 | 2013 | 0 |